Experts Tackle Bronchiolitis Obliterans Syndrome Part Three, From Zambon USA

Presented by Zambon USA

ISHLT Voices returns with another podcast presented by Zambon USA exploring bronchiolitis obliterans syndrome (BOS). BOS is one of the most common forms of chronic lung transplant rejection, and in part three of this series, experts take a deep dive into CLAD phenotype differentiation, current gaps in diagnosis and management of BOS, emerging treatment strategies, and lastly, discuss the advances made in BOS diagnosis and management over the last decade.

Steven Hays, MD
Medical Director, Advanced Lung Disease and
Lung Transplant Programs
University of California, San Francisco
San Francisco, CA USA

Justin P. Rosenheck, DO
Clinical Assistant Professor of Internal Medicine
Division of Pulmonary, Critical Care and Sleep Medicine, Lung Transplant Program
The Ohio State University Wexner Medical Center
Columbus, OH USA

This episode was created for ISHLT Voices and sponsored by Zambon USA, Ltd.

The content of this industry-supported ISHLT Voices podcast is developed entirely by our industry partner, Zambon. This is not an official ISHLT educational program, and therefore is not eligible for CME under the ISHLT.